中美在竞争第一款真正的AI创新药

虎嗅
17 Jun

在生物医药领域,美国对AI制药寄予了厚望,以期能继续保持对中国领先的身位。但第一款真正意义上的AI创新药,也有可能出自中国。全球医药巨头继续向中国加码,这回轮到AI制药了。而且,单笔交易的潜在总金额超过50亿美元,完全不亚于美国AI制药企业在热钱涌动的疫情期间取得的成绩。中国在创新药领域正在形成的优势,并不在于便宜,而在于它似乎最有可能起效。上周末,石药集团宣布与阿斯利康(AstraZeneca)...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10